JANSSEN-CILAG AS
Score · fiscal year 2023
43of 100
How to read this: the company is ahead of 39 % of companies in the Morning class Large in the same sector in 2023. What does this mean?
Rank in the Morning class Large: 285 of 465 · What are Morning company classes?
Place in the whole sector: 12,852 of 21,201 · Handel
Profile
Cheetah · Sprinter
High profitability, lower solidity
Position against comparable companies in 2023, not a verdict on the company. Based on profitability 75 and solidity 16 out of 100 among companies in the Morning class Large in the same sector in 2023. Methodology
Against the sector
JANSSEN-CILAG AS is 5 points below the median for companies in the Morning class Large in the same sector in 2023.
Median score 48 among 465 companies.
Against companies in the Morning class Large in the same sector in 2023: operating margin 5.5% (median 2.3%) and equity ratio 11.7% (median 28.7%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 1,395 MNOK | 1,081 MNOK |
| Operating margin | 5.5% | 2.3% |
| Profit margin | 5.6% | 2.4% |
| Return on assets | 15.2% | 10.3% |
| Equity ratio | 11.7% | 28.7% |
| Debt-to-equity | 7.56 | 2.46 |
| Current ratio | 1.11 | 1.28 |
| Revenue growth | – | 0.8% |
| Revenue per employee | 24.05 MNOK | 11.26 MNOK |
The median and “ahead of” refer to companies in the Morning class Large in the same sector in 2023. The bar shows the share of companies the figure is ahead of.
With an index of 43, JANSSEN-CILAG AS does better than 39% of companies in the Morning class Large in the same sector (465 companies) in 2023.
Score 2023–2025
- JANSSEN-CILAG AS
- Median: companies in the Morning class Large in the same sector
What the numbers say
JANSSEN-CILAG AS had an operating margin of 5.5% and an equity ratio of 11.7% in 2023, and ranks 12,852 of 21,201 in Handel.
This text is generated automatically from the 2023 accounts.
Three simple methods
The methods give between 63 MNOK and 646 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 646 MNOK |
| EV/EBIT | 8.0 | 637 MNOK |
| P/B | 1.0 | 63 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.9% of the debt in 2023. The policy rate averaged 3.54 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of 1.5%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 75 | weight 30% |
|---|---|---|
| Solidity | 16 | weight 25% |
| Liquidity | 30 | weight 15% |
| Growth | – | no data, left out |
| Consistency | 37 | weight 15% |
Index version 2. Data completeness 85%: the share of the weights that had data.
Questions and answers
How profitable is JANSSEN-CILAG AS?
The operating margin was 5.5% in 2023, against a median of 2.3% among companies in the Morning class Large in the same sector. Return on assets was 15.2%.
How solid is JANSSEN-CILAG AS?
The equity ratio was 11.7% in 2023 (median 28.7%). Debt-to-equity was 7.56 (median 2.46).
What is the liquidity of JANSSEN-CILAG AS like?
The current ratio was 1.11 in 2023 (median 1.28).
How does JANSSEN-CILAG AS compare in Handel?
JANSSEN-CILAG AS ranks 12,852 of 21,201 in Handel for 2023. Among companies in the Morning class Large it is number 285 of 465.
Group accounts
The company is registered as part of a group, but we have no group accounts for it. Group accounts are filed by the parent company, and open data does not say which company that is.
Read the figures with care: a company in a group can look strong because of group contributions, or weak because dividends go up to the parent. The figures are indications, not the full picture.
We do not show the group structure, because open data does not say who owns whom.
Public contracts
- Contracts awarded since 2024
- 1
- Total awarded value since 2024
- value not stated
- Framework agreements
- 1
- Left out of the total: the value is a ceiling, not actual spend.
| Date | Buyer | Notice | Value |
|---|---|---|---|
| 2 January 2025 | Oslo Universitetssykehus HF (hovedenhet) | 76710 3D elektrofysiologisk mapping system | value not stated |
Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.
Source: Doffin (DFØ), fetched 27 October 2026. Winners are matched on organisation number.
Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0
From the Central Coordinating Register
- Org. no.
- 975332802
- Legal form
- AS · part of a group
- Sector
- Handel (46.460)
- Morning company class
- Large
- Employees
- 58 registered 10 October 2026
- Founded
- 22 May 1995 31 years in operation
- Share capital
- 0.09 MNOK
- Business address
- Drammensveien 288, 0283 OSLO
- Municipality
- Oslo rank 63–220 of 357 in Norway
- Latest accounts filed
- 2025
- LEI
- 5493002DZO7KRZR1UR54 renews 18 July 2027
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Mario Klesse
- Chair of the board
- Anne Merete Sveaass
- Board member
- Anne Håvi
- Board member
- Charlotte Krogh
- Board member
- Mario Klesse
- Board member
- Raphael Patricot
- Auditor
- PRICEWATERHOUSECOOPERS AS
- Accountant
- AZETS INSIGHT AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
- Parent company
- Janssen-Cilag Aktiebolag (Sweden)
- Ultimate parent
- Johnson & Johnson (USA)
Foreign-owned according to GLEIF.
Source: GLEIF (Global Legal Entity Identifier Foundation), fetched 29 October 2026. The parent is the one the company itself reported to GLEIF.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 28 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 43 | 40 | 34 | |
| Rank | 12,852 | 15,207 | 17,962 | |
| Operating margin | 5.5% | 4.2% | 4.6% | |
| Return on assets | 15.2% | 13.5% | 15.8% | |
| Equity ratio | 11.7% | 12.6% | 0.1% | |
| Current ratio | 1.11 | 1.12 | 0.98 | |
| Revenue growth | – | −0.7% | 2.0% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 1,394.6 MNOK | 1,385.0 MNOK | 1,412.9 MNOK |
| Operating profit | 76.7 MNOK | 58.9 MNOK | 65.2 MNOK |
| Profit before tax | 77.7 MNOK | 69.3 MNOK | 71.1 MNOK |
| Net profit | 64.6 MNOK | 52.2 MNOK | 54.1 MNOK |
| Financial expenses | 4.4 MNOK | 1.0 MNOK | 0.7 MNOK |
| Total assets | 541.0 MNOK | 520.7 MNOK | 455.4 MNOK |
| Current assets | 528.9 MNOK | 511.7 MNOK | 446.9 MNOK |
| Equity | 63.2 MNOK | 65.4 MNOK | 0.5 MNOK |
| Retained earnings | 63.1 MNOK | 65.3 MNOK | 0.4 MNOK |
| Total liabilities | 477.8 MNOK | 455.4 MNOK | 455.0 MNOK |
| Current liabilities | 475.2 MNOK | 455.4 MNOK | 454.8 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 28 October 2026, accounts id 5302467.
Further
Similar companies
- KOSAN GAS NORGE AS index 43, rank 12,806 · compare
- L'OREAL NORGE AS index 43, rank 12,821 · compare
- BONAVENTURA SALES AS index 43, rank 12,834 · compare
- MSD ANIMAL HEALTH NORGE AS index 43, rank 12,854 · compare
- VIKEN AT MARKET AS index 43, rank 12,858 · compare